FDA sets draft rules for biotech drug copies – Reuters India
Under the U.S. healthcare reform law passed in 2010, brand-name biotech drugs - ranging from relatively simple molecules like insulin to complex antibodies used to treat cancer - were granted a 12-year period of market exclusivity, after which ...
Subscribe to LegalLaw247.Com Newsletter
